CLINICAL_TRIALS
trial_result
· 2022-03-14
Clinical Trial Update: A Study of Bermekimab in Patients With Hidradenitis Suppurativa [Phase 2]
Summary
Phase 2 trial update for bermekimab in hidradenitis suppurativa has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2022-03-14